tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Kristen Kluska, 160 are a BUY (90.91%), 16 are a HOLD (9.09%).
Analyst Kristen Kluska, currently employed at CANTOR FITZGERALD, carries an average stock price target met ratio of 38.6% that have a potential upside of 40.97% achieved within 102 days.
Kristen Kluska’s has documented 344 price targets and ratings displayed on 29 stocks. The coverage is on Healthcare, Industrials sectors.
Most recent stock forecast was given on CLDX, Celldex Therapeutics at 29-Jan-2025.
Analyst best performing recommendations are on OCGN (OCUGEN).
The best stock recommendation documented was for OCGN (OCUGEN) at 2/3/2021. The price target of $4 was fulfilled within 2 days with a profit of $1.19 (42.35%) receiving and performance score of 211.74.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$67
$42.51 (173.58%)
$67
8 days ago
(29-Jan-2025)
4/19 (21.05%)
$41.49 (162.64%)
62
Buy
$80
$55.51 (226.66%)
$80
1 months 17 days ago
(20-Dec-2024)
6/27 (22.22%)
$55.5 (226.53%)
256
Hold
$37
$12.51 (51.08%)
$27
5 months 25 days ago
(12-Aug-2024)
2/3 (66.67%)
$3.54 (10.58%)
8
Buy
$90
$65.51 (267.50%)
$72
11 months 10 days ago
(27-Feb-2024)
0/4 (0%)
$38.96 (76.33%)
Buy
$68
$43.51 (177.66%)
$70
1 years 5 months 26 days ago
(11-Aug-2023)
0/3 (0%)
$37.77 (124.94%)
Which stock is Kristen Kluska is most bullish on?
Which stock is Kristen Kluska is most reserved on?
What Year was the first public recommendation made by Kristen Kluska?
